TRIMZED 35

MRP
181/Strip

Description
Each Film Coated Modified Release Tablet Contains: Trimetazidine Dihydrochloride IP 35 mg

Doses
As Directed by Physician

Indication
Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent that improves myocardial glucose utilization by inhibiting fatty acid metabolism, also known as a fatty acid oxidation inhibitor.